Nedbank Group Limited (NMSE:NBK)

Verve Therapeutics Ratios and Metrics

Market cap in millions NAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	114,323	131,490	101,707	103,322	84,933	62,925
Market Cap Growth	29.28%	29.28%	-1.56%	21.65%	34.98%	-38.91%
Last Close Price	244.81	268.88	193.31	172.80	133.02	95.89
PE Ratio	6.80	7.82	6.57	7.25	7.56	18.16
PS Ratio	1.75	2.01	1.65	1.84	1.65	1.57
PB Ratio	0.91	1.04	0.84	0.89	0.78	0.63
Debt / Equity Ratio	0.66	0.66	0.66	0.67	1.02	1.40
Return on Equity (ROE)	15.06%	15.06%	14.46%	13.69%	11.80%	4.48%
Return on Assets (ROA)	1.35%	1.35%	1.33%	1.25%	1.01%	0.38%
Earnings Yield	14.72%	12.80%	15.23%	13.79%	13.23%	5.51%
FCF Yield	-63.06%	-54.83%	-20.78%	-55.47%	-12.63%	-62.31%
Dividend Yield	8.75%	7.71%	9.91%	9.52%	8.95%	-
Payout Ratio	58.02%	58.02%	56.29%	54.78%	19.38%	100.95%
Buyback Yield / Dilution	2.17%	2.17%	2.28%	-1.18%	-1.25%	-0.26%
Total Shareholder Return	10.92%	9.88%	12.19%	8.34%	7.70%	-0.26%

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.